Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease

Código QR

Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease

Abstract Non-alcoholic fatty liver disease (NAFLD) affects 25% of the adult population globally. Since liver fibrosis is the most important predictor of liver-related complications in patients with NAFLD, identification of patients with advanced fibrosis among at-risk individuals is an important iss...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Katharine M. Irvine, Satomi Okano, Preya J. Patel, Leigh U. Horsfall, Suzanne Williams, Anthony Russell, Elizabeth E. Powell
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/3622a3451cc5424a98c6081d430e546b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinases
por: Edward A Lin, et al.
Publicado: (2009)

Clinical significance of matrix metalloproteinase (MMP)-2 and MMP-9 expression in laryngeal squamous cell carcinoma
por: Rašić Dejan, et al.
Publicado: (2021)

Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo.
por: Ayumi Taguchi, et al.
Publicado: (2014)

Usefulness of matrix metalloproteinase-7 in saliva as a diagnostic biomarker for laryngopharyngeal reflux disease
por: Nu-Ri Im, et al.
Publicado: (2021)

Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
por: Erik Forsblom, et al.
Publicado: (2021)

An interplay of microglia and matrix metalloproteinase MMP9 under hypoxic stress regulates the opticin expression in retina
por: Satish Patnaik, et al.
Publicado: (2021)

Diagnostic Value of Serum and Saliva Matrix Metalloproteinase13 (MMP13) in Oral Squamous Cell Carcinoma
por: T Ghanbarnia, et al.
Publicado: (2020)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
por: Yu. V. Korenovsky, et al.
Publicado: (2012)

Integrated Multi-Omics Investigations of Metalloproteinases in Colon Cancer: Focus on MMP2 and MMP9
por: Miriam Buttacavoli, et al.
Publicado: (2021)

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) are localized in the nucleus of retinal Müller glial cells and modulated by cytokines and oxidative stress.
por: Eun-Jin Lee, et al.
Publicado: (2021)

Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer’s disease
por: Archontia Kaminari, et al.
Publicado: (2017)

Regulation of amyloid-β levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells
por: Sadaf Dorandish, et al.
Publicado: (2021)

miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin β1 and matrix metalloproteinase2 (MMP2).
por: Heyong Wang, et al.
Publicado: (2013)

The role of matrix metalloproteinases in the myocardial remodeling
por: Vladlen V. Bazylev, et al.
Publicado: (2020)

Effect of prostaglandin analogs on matrix metalloproteinases and tissue inhibitor of metalloproteinases in eyelid muscle specimens
por: Karli S, et al.
Publicado: (2018)

Dynamics of Matrix Metalloproteinases in Local Cold Injury
por: M. I. Mikhailichenko, et al.
Publicado: (2019)

Dentinogenic effects of extracted dentin matrix components digested with matrix metalloproteinases
por: Motoki Okamoto, et al.
Publicado: (2018)

The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target
por: Junya Ke, et al.
Publicado: (2021)

Dentine matrix metalloproteinases as potential mediators of dentine regeneration
por: E Guirado, et al.
Publicado: (2021)

Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliation syndrome
por: Kara S, et al.
Publicado: (2014)

MARKERS OF SYSTEMIC INFLAMMATION AND MATRIX METALLOPROTEINASE / TISSUE INHIBITOR OF METALLOPROTEINASES SYSTEM AT DIFFERENT STAGES OF CHRONIC HEART FAILURE
por: E. N. Egorova, et al.
Publicado: (2014)

<i>Bacteroides fragilis</i> Enterotoxin Upregulates Matrix Metalloproteinase-7 Expression through MAPK and AP-1 Activation in Intestinal Epithelial Cells, Leading to Syndecan-2 Release
por: Jong Ik Jeon, et al.
Publicado: (2021)

Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
por: Hee Kyung Shin, et al.
Publicado: (2021)

Tissue mRNA expression in rat of newly described matrix metalloproteinases
por: BERNAL,FABIÁN, et al.
Publicado: (2005)

NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma
por: Sun Y, et al.
Publicado: (2017)

Extracellular Matrix Remodeling by Fibroblast-MMP14 Regulates Melanoma Growth
por: Elke Pach, et al.
Publicado: (2021)

Nutricosmetic effects of Asparagus officinalis: a potent matrix metalloproteinase-1 inhibitor
por: Suwannee Sriyab, et al.
Publicado: (2021)

Circulating matrix metalloproteinases in infective endocarditis: a possible marker of the embolic risk.
por: Franck Thuny, et al.
Publicado: (2011)

ASSOCIATION OF MATRIX METALLOPROTEINASES GENE POLYMORPHISM WITH CLINICAL MANIFESTATIONS OF BRONCHIAL ASTHMA IN CHILDREN
por: A. A. Lebedenko, et al.
Publicado: (2018)

Inhibitory effects of zinc hyaluronate on synoviocyte growth and matrix metalloproteinase-9 activity
por: Seiji Saito, et al.
Publicado: (2009)

Colocalization with MMP-7 in the Distal Colon is Crucial for Syndecan-2 Shedding in Dextran Sulfate Sodium-Induced Colitis Mice
por: Hong H, et al.
Publicado: (2021)

MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation.
por: Peter Chen, et al.
Publicado: (2009)

P2X7 receptor antagonism modulates IL-1β and MMP9 in human atherosclerotic vessels
por: Maria Lombardi, et al.
Publicado: (2017)

Disparate effects of MMP and TIMP modulation on coronary atherosclerosis and associated myocardial fibrosis
por: Georgios Kremastiotis, et al.
Publicado: (2021)

The cross-talk between matrix metalloproteinase-9, RANKL/OPG system and cardiovascular risk factors in ovariectomized rat model of postmenopausal osteoporosis.
por: Maha Sabry, et al.
Publicado: (2021)

Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-<i>p</i>-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver Disease
por: Russell R. Fling, et al.
Publicado: (2021)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Osama Hamdy, et al.
Publicado: (2021)

Photorefractive keratectomy: measuring the matrix metalloproteinase activity and chondroitin sulfate concentration in tear fluid
por: Tetsuya Mutoh, et al.
Publicado: (2010)

Histopathologic Findings Associated With Matrix Metalloproteinases Proceeding to Recurrence of Primary Spontaneous Pneumothorax in Adolescents
por: Chih-Yung Chiu, et al.
Publicado: (2021)

Peculiarities of synthesis of matrix metalloproteinase-9 in the lungs during experimental development of distress syndrome
por: E. V. Prutkina, et al.
Publicado: (2013)